Subungual abscess: A new ungual side-effect related to docetaxel therapy [13]

British Journal of Dermatology

Volumn 143, Issue 2, 2000, Pages 462-463

  Vanhooteghem, O ^a   Richert, B ^a   Vindevoghel, A ^a   Vandenbossche, L ^a   Vandeveire, A ^a   De La Brassinne, M ^a  

^a Clinique & Maternite Sainte Elisabeth Namer   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIRUBICIN; FORMESTANE; FUSIDATE SODIUM; TAMOXIFEN CITRATE;

ABSCESS; ADULT; ANTIBIOTIC THERAPY; BLEEDING; BONE METASTASIS; BREAST CANCER; CASE REPORT; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FINGER; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; LETTER; LIVER METASTASIS; LUNG METASTASIS; ONYCHOLYSIS; PRIORITY JOURNAL; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; THUMB;

EID: 0033839239     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2000.03692.x     Document Type: Letter

References (8)

1. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: A phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer
2. Phase II trial of docetaxel in patients with platonium-refractory advanced ovarian cancer
3. Phase II study of docetaxel for recurrent or metastatic non-small-cell lung cancer
4. Effets secondaires cutaneomuqueux des perfusions continues de 5-fluorouracile
5. Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia
6. Docetaxel-induced subungual hemorrhage
7. Nail changes secondary to docetaxel (Taxotere)
8. Imputabilite des effets inattendus ou toxiques des medicaments. Actualisation de la mehode utilisee en France